News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GALAKATOS NICHOLAS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/21/2019 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 7,500 options to buy
@ $6.12, valued at
$45.9k
|
|
| 03/27/2019 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 4,410 options to buy
@ $23.34, valued at
$102.9k
|
|
| 01/22/2019 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.66, valued at
$84.9k
|
|
| 10/02/2018 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Converted 361,829 shares
@ $0
Converted 323,341 shares
@ $0
Converted 412,583 shares
@ $0
Bought 453,395 shares
@ $15, valued at
$6.8M
Converted 7,500,000 convertible preferred
@ $0
Converted 6,702,213 options to buy
@ $0
Converted 8,552,024 options to buy
@ $0 |
|
| 09/19/2018 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 85,823 shares
@ $15.99, valued at
$1.4M
Exercised (in-or-at-the-money) 162,408 warrants
@ $8.448, valued at
$1.4M
|
|
| 07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2017 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on NanoString Technologies Inc |
| 09/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/05/2016 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC |
| 02/10/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 103,123 shares
@ $0.19, valued at
$19.6k
Sold 230,507 shares
@ $0.16, valued at
$36.9k
|
|
| 02/05/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 82,583 shares
@ $0.15, valued at
$12.4k
Sold 500,026 shares
@ $0.14, valued at
$70k
Sold 832,881 shares
@ $0.2, valued at
$166.6k
|
|
| 02/02/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 52,826 shares
@ $0.26, valued at
$13.7k
Sold 140,000 shares
@ $0.2, valued at
$28k
Sold 176,306 shares
@ $0.17, valued at
$30k
|
|
| 01/28/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 69,425 shares
@ $0.3, valued at
$20.8k
Sold 209,984 shares
@ $0.27, valued at
$56.7k
Sold 32,521 shares
@ $0.26, valued at
$8.5k
|
|
| 01/13/2016 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Sold 999 shares
@ $65.45, valued at
$65.4k
Sold 1,001 shares
@ $66.33, valued at
$66.4k
Sold 501 shares
@ $65.45, valued at
$32.8k
Sold 499 shares
@ $65.33, valued at
$32.6k
|
|
| 01/05/2016 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 7,828 options to buy
@ $14.71, valued at
$115.1k
|
|
| 12/14/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Sold 533 shares
@ $63.9, valued at
$34.1k
Sold 1,467 shares
@ $64.63, valued at
$94.8k
Sold 267 shares
@ $63.91, valued at
$17.1k
Sold 733 shares
@ $64.63, valued at
$47.4k
|
|
| 11/19/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Sold 1,000 shares
@ $60, valued at
$60k
Sold 500 shares
@ $60, valued at
$30k
|
|
| 11/12/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Sold 1,000 shares
@ $60, valued at
$60k
Sold 500 shares
@ $60, valued at
$30k
Sold 1,000 shares
@ $58.69, valued at
$58.7k
Sold 500 shares
@ $58.69, valued at
$29.3k
|
|
| 11/04/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Sold 1,000 shares
@ $54, valued at
$54k
Sold 500 shares
@ $54, valued at
$27k
|
|
| 06/30/2015 |
4
| GALAKATOS NICHOLAS (10% Owner) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Converted 1,618,676 shares
@ $0
Converted 757,117 shares
@ $0
Bought 376,695 shares
@ $12, valued at
$4.5M
Converted 20,800,000 preferred shares
@ $0
Converted 9,728,971 preferred shares
@ $0
Granted 11,094 options to buy
@ $12.21, valued at
$135.5k
|
|
| 06/29/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Gifted 1,020 shares
@ $0 |
|
| 06/17/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 1,529 shares
@ $14.27, valued at
$21.8k
Sold 39,701 shares
@ $14.3, valued at
$567.7k
|
|
| 06/12/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 25,168 shares
@ $14.27, valued at
$359.1k
Sold 6,430 shares
@ $14.25, valued at
$91.6k
|
|
| 06/10/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 2,662 shares
@ $14.25, valued at
$37.9k
Sold 13,000 shares
@ $14.26, valued at
$185.4k
Sold 8,987 shares
@ $14.32, valued at
$128.7k
|
|
| 06/08/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Granted 7,000 options to buy
@ $48.3, valued at
$338.1k
Granted 1,750 restricted stock units
@ $0 |
|
| 06/03/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 15,010 shares
@ $14.29, valued at
$214.5k
Sold 11,014 shares
@ $14.25, valued at
$156.9k
Sold 10,450 shares
@ $14.32, valued at
$149.6k
|
|
| 05/28/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Disposed of 1,554,744 shares
@ $0 |
|
| 05/28/2015 |
4
| GALAKATOS NICHOLAS (Director) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Disposed of 1,554,744 shares
@ $0
Acquired 7,319 shares
@ $0
Acquired 3,137 shares
@ $0 |
|
| 03/24/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 27,115 shares
@ $14.53, valued at
$394k
Sold 26,300 shares
@ $14.44, valued at
$379.8k
|
|
| 03/19/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 79,307 shares
@ $14.67, valued at
$1.2M
Sold 25,000 shares
@ $14.68, valued at
$367k
Sold 50,012 shares
@ $14.61, valued at
$730.7k
|
|
| 01/30/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed of 3,139,447 shares
@ $0 |
|
|
|
|